NAS10029,403−1.38%S&P7,720−0.31%GOLD$4,032−0.48%BTC$80,460−0.99%VIX16.61−1.77%latest tape · as of 20:02 UTC
The Screen · Technology · Information Technology Services
Parsons Corporation
PSN · the NYSE · USD · Market cap $4.8B · 21,000 employees
Parsons Corporation provides design, engineering and technical services, and smart and agile software for the United States federal government and critical infrastructure customers worldwide.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.86, read 2026-10-28
Ethical passes the values gate
Price50.52 USD
Fair value66.00
Ethical score70.0/100
Our investment reviews on this name
2026-10-22Read Markup44.65+13.1% to today ✓Distribution gives way to Markup after a 9% rise in 11 days
2026-10-11Read Distribution41.01+23.2% to today Markdown gives way to Distribution
2026-10-02Read Markdown41.01+23.2% to today Markup gives way to Markdown after a 28% slide in 13 weeks
2026-07-02Read Markup56.70-10.9% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Parsons Corporation holds its Markup at $50.52. Consolidating, no directional conviction, held for 41 days.
As held on the ledger · 2026-10-28
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 41 days
Price at the screen
$50.52
Valuation
30.79 trailing · 13.06 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.71
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
23.96%
Below 33%
Interest-bearing debt is just 24.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
20.78%
Below 49%
Money owed to the company is 20.8% of assets, under the 49% limit.
Pass
Revenue purity
0.11%
Below 5%
Only 0.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Parsons clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 24%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PSN's ethical verdict changes
Today PSN passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-28 screen. The gold marker is the market price at the same screen. A 30.6% margin of safety to the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits +19% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Government Contractor Looks Cheap But Growth Has Stalled
Parsons builds engineering software and technical services that keep federal networks and critical infrastructure running. The business clears our ethical screen without flags, yet revenue is already shrinking 4 percent and margins sit at just 4 percent. That combination leaves little room for the 43 percent margin of safety implied by our $80 fair value against the current $56 price.
Forward earnings trade at 15 times, which looks modest until you notice return on equity of only 11 percent and an unknown competitive edge. Eleven analysts still carry a buy rating with a $69 median target, but those forecasts rest on the same flat government spending that produced the current dip. Low multiples on declining top-line numbers rarely signal bargains in this sector.
Cyclical budget cycles and thin profitability remain the real constraints here. Without clearer evidence of renewed contract momentum, the discount is more warning than opportunity. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PSN trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-28Markup$44.65+0.0%Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (11 analysts) rates it buy, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markup$44.65+0.0%Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (11 analysts) rates it buy, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markup$44.65+0.0%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (11 analysts) rates it buy, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markup$44.65+0.0%Entry 13
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (11 analysts) rates it buy, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markup$44.65+0.0%Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (11 analysts) rates it buy, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markup$44.65+0.0%Entry 11
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (11 analysts) rates it buy, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markup · changed$44.65+0.0%Entry 10
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (11 analysts) rates it buy, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Distribution$44.65+1.2%Entry 9
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (11 analysts) rates it buy, with a mean price target of $70. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Distribution$44.10+7.5%Entry 8
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 7.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (11 analysts) rates it buy, with a mean price target of $70.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (11 analysts) rates it buy, with a mean price target of $70.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
